WALDENSTRÖM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial explores new drug for blood cancers in japanese patients
Disease control CompletedThis early-phase study tested a new drug called nemtabrutinib in 7 Japanese adults with certain blood cancers (like chronic lymphocytic leukemia). The main goals were to check the drug's safety and how the body processes it. Researchers looked for side effects and measured drug l…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Blood test could replace bone marrow biopsy for rare blood cancer monitoring
Knowledge-focused CompletedThis study looked at 45 adults newly diagnosed with Waldenström's disease, a rare blood cancer. Researchers compared different lab methods to detect a common genetic mutation (MYD88 L265P) in blood and bone marrow samples. The goal was to find less invasive ways to diagnose and t…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC